Reply
 
Thread Tools Display Modes
Old 12-16-2008, 09:04 AM #1
legzzalot's Avatar
legzzalot legzzalot is offline
Magnate
 
Join Date: Nov 2008
Location: Fredericksburg, VA
Posts: 2,091
15 yr Member
legzzalot legzzalot is offline
Magnate
legzzalot's Avatar
 
Join Date: Nov 2008
Location: Fredericksburg, VA
Posts: 2,091
15 yr Member
Default

See? This is why you guys rock!
legzzalot is offline   Reply With QuoteReply With Quote
Old 12-16-2008, 07:57 PM #2
Gazelle's Avatar
Gazelle Gazelle is offline
Senior Member
 
Join Date: Jan 2008
Location: somewhere over the rainbow
Posts: 1,362
15 yr Member
Gazelle Gazelle is offline
Senior Member
Gazelle's Avatar
 
Join Date: Jan 2008
Location: somewhere over the rainbow
Posts: 1,362
15 yr Member
Default

I was first going to say that it sounded a lot like some people's sex lives, but that's really WAY COOL if it works and they get it approved!

I'd shoot up 2x a year. Keep us posted about it please!
__________________
A Hairy Chicken Is Better Than A Hairy Hand!
Gazelle is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
dmplaura (04-01-2009), ewizabeth (04-01-2009), weegot5kiz (12-26-2008)
Old 12-26-2008, 04:15 PM #3
CayoKay's Avatar
CayoKay CayoKay is offline
Fabulous Belizean Member
 
Join Date: Jan 2008
Location: Belize
Posts: 2,508
15 yr Member
CayoKay CayoKay is offline
Fabulous Belizean Member
CayoKay's Avatar
 
Join Date: Jan 2008
Location: Belize
Posts: 2,508
15 yr Member
Default

hot off the wire, a Bloomberg Exclusive:

BioMS May Give Lilly $5 Billion Cure for Expiring Drug Patents

By Kelly Riddell

Dec. 26 (Bloomberg) -- BioMS Medical Corp., a one-drug biotechnology company in Edmonton, Alberta, may hold a partial answer as to how Eli Lilly & Co. will replace $9.9 billion in sales threatened by expiring patents.

Lilly signed a $497 million licensing and development agreement for BioMS’s dirucotide, potentially the first treatment for advanced forms of multiple sclerosis to come to market. The medicine, which entered final trials, has so far escaped side effects such as influenza-like symptoms, fatigue and skin cancer that were reported by Basel, Switzerland-based Novartis AG on fingolimod, another late-stage drug in testing for the disease.

A mid-level study of dirucotide, involving 218 subjects, had “very impressive features to it,” according to Bill Chin, Lily’s vice president of discovery and clinical investigation. The drug represents a chance for “a breakthrough,” he said.


http://www.bloomberg.com/apps/news?p...ZNs&refer=home
__________________
And the trouble is... if you don't risk anything, you risk even more. - Erica Jong
CayoKay is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
4boysmom (12-28-2008), dmplaura (12-26-2008), legzzalot (12-30-2008)
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
January is another year and hopefully a year of SUCCESS for us! :) froglady Weight Loss & Healthy Living 14 01-13-2009 11:27 PM
New PM Dr. = New Meds Coffeebean Reflex Sympathetic Dystrophy (RSD and CRPS) 9 06-16-2008 10:51 AM
Jim “Catfish” Hunter Chapter Named Chapter of the Year for Second Year in a Row BobbyB ALS News & Research 0 03-10-2008 11:18 AM


All times are GMT -5. The time now is 06:36 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.